You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海利生物(603718.SH)擬清算並註銷冉裕科技
格隆匯 08-21 08:57

格隆匯8月21日丨海利生物(603718.SH)公佈,公司及公司全資子公司上海牧海生物科技有限公司(以下簡稱“牧海生物”)通過受讓上海冉裕科技合夥企業(有限合夥)(以下簡稱“冉裕科技”)股權以及向冉裕科技增資的形式,總計現金投資1.01億元,間接持有上海裕隆生物科技有限公司(以下簡稱“裕隆生物”)18.605%的股權。

2017年12月,裕隆生物與上海芮昱投資中心(有限合夥)、上海約實科技合夥企業(有限合夥)簽訂《增資擴股協議》,冉裕科技未同比例增資,故冉裕科技持有裕隆生物的股比例稀釋為17.761%。2019年4月22日和2019年7月11日,公司分別召開第三屆董事會第九次會議和第三屆董事會第十二次會議,審議通過了《關於轉讓上海裕隆生物科技有限公司股權的議案》和《關於轉讓上海裕隆生物科技有限公司股權新增受讓方的議案》。

截至目前,裕隆生物已經完成了相關工商變更手續,冉裕科技也已收到相關股權轉讓款1.15億元,因此冉裕科技已經實現了投資收益並已全部完成退出,為優化資源整合,降低管理成本,公司決定對冉裕科技終止經營,進行清算並註銷。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account